"Compared to the reality of the drug industry, my book reads like a vacation post card"
- John le Carré, Author of The Constant Gardner
 
Top News arrow News / Infomails
News and Infomails from AHRP
NAMI Acknowledges: 56% of Budget Comes from Drug Companies PDF Print E-mail
Wednesday, 06 May 2009
In its response to Sen. Grassley's probe, The National Alliance on Mental Illness (NAMI) acknowledges that a majority of its funds over the last five years, 56% on average, have come from drug corporations.
Read more...
 
Merck Paid Elsevier to Publish Phony Peer-Review Journal PDF Print E-mail
Tuesday, 05 May 2009
Merck is reported to have created a fake "peer-reviewed" journal to present favorable data that made its potentially fatal drugs--Fosamax and Vioxx--look good. 
Read more...
 
Rebecca Riley’s doctor now the target of a grand jury PDF Print E-mail
Saturday, 02 May 2009
The Patriot Ledger reports that Rebecca Riley's psychiatrist, Dr. Kayoko Kifuji, is under criminal investigation by a grand jury.
Read more...
 
FDA-US Justice Dept. Withdraw Amicus Brief in Colacicco v. Apotex Inc, PDF Print E-mail
Friday, 01 May 2009
“Every failure-to-warn case against a drug company has been affected by Wyeth”
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 127 - 140 of 652
(C) 2010 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]